investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Smead Capital Management, Inc. Q3 2022 vs. Q4 2022: A Look at 13F Holdings

Ava Hoppe | 6 May, 2023

Smead Capital Management, Inc. recently filed its 13F for the third and fourth quarter of 2022, which shows its holdings and changes in holdings for various companies. While the fund added stocks to some companies, it reduced its stake in others.

During the third quarter, the fund increased its stake in Occidental Pete Corp, which went up by 23%, with the company now holding 6,831,652 shares. In terms of value, the stake went up from $349,943,000 to $430,325,000, an increase of 23%.

Another company that saw a significant increase in value was Simon Ppty Group Inc New, with the fund increasing its stake by 50.7% during the fourth quarter. Smead Capital Management, Inc. now holds 2,384,027 shares in the company, up from 2,071,191 shares in the previous quarter. The value of its stake also went up from $185,889,000 to $280,075,000.

In contrast, the fund reduced its stake in Continental Res Inc entirely, selling off all of its 7,052,830 shares during Q4, worth $471,200,000, after previously holding them in Q3. Similarly, the fund sold off all of its shares in Frontline LTD, Liberty Global plc, and Ovintiv Inc. during Q4.

Let's take a closer look at some of the individual companies in the fund's portfolio:

Occidental Pete Corp: As one of the biggest oil and gas exploration and production companies, Occidental Pete Corp is an important holding in the fund's portfolio. While the company has struggled in recent years, the fund seems to remain bullish on the stock.

Merck & Co Inc: Merck & Co is a pharmaceutical giant that has been in the news frequently due to its COVID-19 vaccine. Smead Capital Management, Inc. increased its stake in the company during Q4 by 9%, which suggests a positive outlook for the pharmaceutical company.

Amgen Inc: Smead Capital Management, Inc. also added to its position in Amgen Inc, which is a biotech company that develops and produces drugs. The fund increased its stake by 9%, with the company now holding 1,142,204 shares.

ConocoPhillips: Another major oil and gas company in the fund's portfolio is ConocoPhillips. The fund increased its stake by 29% during the fourth quarter, with the company now holding 2,339,167 shares in the company.

Lennar Corp: Lennar Corp, a home construction company, is another stock that the fund is bullish on. During the fourth quarter, Smead Capital Management, Inc. increased its stake by 16%, with the company now holding 2,962,690 shares.

Overall, the Smead Capital Management, Inc. 13F filings show a mix of bullish and bearish positions on various stocks. While the fund reduced its stake in some companies, it also added to others, indicating its confidence in those companies' growth prospects. It will be interesting to see what changes the fund makes in the coming quarters as the market continues to evolve.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.